Pharmaceuticals in Marine and Coastal Environments

1. Point and diffuse sources of pharmaceuticals in coastal zones<br>2. Occurrence spatiotemporal distribution and environmental fate of pharmaceutical residues in urban estuaries<br>3. Pharmaceutical active compounds in marine and coastal environments of arid and semi-arid countries in the Arab Region<br>4. Occurrence and distribution of antibiotics and antibiotic resistance determinants in coastal environments <br>5. Occurrence and environmental fate of pharmaceuticals, personal care products and illicit drugs (PPCPIDs) in tropical ecosystems<br>6. Environmental risk assessment of pharmaceutical and personal care products in estuarine and coastal waters<br>7. New sampling methods for detecting pharmaceutical residues in seawater and sediments<br>8. Present and future challenges in the multiresidue determination of pharmaceuticals in marine samples <br>9. Analytical strategies to detect and quantify pharmaceutical residues in marine biota<br>10. Sources and occurrence of pharmaceutical residues in offshore seawater<br>11. Occurrence of pharmaceutical residues in marine sediments<br>12. Pharmaceuticals residues in the pristine Antarctic ecosystem  <br>13. On the search of a suitable indicator of pharmaceutical pollution in marine environments<br>14. Effective biomarkers to assess the toxicity of pharmaceutical residues on marine bivalves<br>15. Metabolic effects of pharmaceuticals in fish<br>16. Pharmaceuticals and aquatic benthic organisms: toxicity and accumulation<br>17. Endocrine disruption of pharmaceuticals on marine organisms: thyroidal, gonadotrophic and behavioural responses<br>18. Biological effects of antidepressants on marine organisms<br>19. Impacts of climate change and ocean acidification on the effects caused by pharmaceutical residues to marine organisms<br>20. Strategies to remove pharmaceutical residues from seawater